What if … cutting-edge cancer radiotherapy didn’t have to cost so much? If patients and their families didn’t have to travel to a centralised cancer care centre for the best treatment? If systems were a quarter of the size and patients could be treated quickly whilst seated or standing?
Nano-X is an innovative cancer treatment system being designed and developed in Australia. Nano-X will change the delivery of radiation therapy from large reference centres to small-town hospitals. An advanced on-board imaging/planning system captures 3D images in real-time, controls the radiation beam, and automatically delivers the right amount of energy to the right tissue. It requires fewer dedicated staff and a much smaller infrastructure footprint.
Nano-X’s first offering is Ruby: a small and real-time adaptive fixed radiotherapy system which treats patients in a seated or standing position. This patient-centred design delivers better medicine, faster treatment times and an improved patient experience. The fixed-beam enables a footprint that is one-quarter the size of existing radiotherapy systems.
Dr Ilana Feain is the founder and CEO of Nano-X where she leads the innovation and commercialisation of the Ruby radiotherapy device. Dr Feain is a world-renowned astrophysicist and prior to joining Nano-X she was the Project Scientist for the Australian Square Kilometre Array Pathfinder Telescope. Dr Feain has an outstanding career in physics, radio astronomy, medical physics and entrepreneurship. She was an Inaugural L'OREAL Australian Women in Science Fellow.
Professor Paul Keall is a founder of Nano-X. He leads the Radiation Physics Lab at the University of Sydney where much of the Nano-X technology was invented. Paul is a serial inventor in real-time radiation therapy, and is widely regarded internationally as a thought leader in this field.
Professor Thomas “Rock” Mackie is an indefatigable innovator, entrepreneur and key opinion leader in medical physics. Among his many commercial successes, Professor Mackie co-founded Tomotherapy and Geometric Corp and has 47 issued patents.
Ben Wright is the Chief Innovations Officer and Head of Investment Strategy at Cicada Innovations, Australia's leading deep technology incubator. Mr Wright is the Director of the Medical Device Commercialisation Training Program and the founder of two seed accelerator programs. He has worked in the commercialisation space for more than 17 years, holds numerous research, management and board positions across life science businesses including Class II medical devices.